Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-17 · accession 0001628280-25-013541 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-18 | 2025-03-17 | CPIX | Galante Joseph C | Dir | A - Grant | $5.17 | +1,000 | 61.9K | +2% | +$5,170 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | A | A | 1,000 | $5.17 | 61,856 | D | — | — | (F1) Restricted stock award will vest 100% on March 17, 2026. |